These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 1761453

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Comparison of cefprozil and cefaclor for treatment of acute urinary tract infections in women.
    Iravani A.
    Antimicrob Agents Chemother; 1991 Sep; 35(9):1940-2. PubMed ID: 1952874
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of cefprozil versus other beta-lactam antibiotics in the treatment of lower respiratory tract infections.
    Ball P.
    Eur J Clin Microbiol Infect Dis; 1994 Oct; 13(10):851-6. PubMed ID: 7889959
    [Abstract] [Full Text] [Related]

  • 7. Cefdinir versus cefaclor in the treatment of uncomplicated urinary tract infection.
    Leigh AP, Nemeth MA, Keyserling CH, Hotary LH, Tack KJ.
    Clin Ther; 2000 Jul; 22(7):818-25. PubMed ID: 10945508
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Cefdinir: a review of its use in the management of mild-to-moderate bacterial infections.
    Perry CM, Scott LJ.
    Drugs; 2004 Jul; 64(13):1433-64. PubMed ID: 15212560
    [Abstract] [Full Text] [Related]

  • 10. Loracarbef versus cefaclor in the treatment of urinary tract infections in women.
    Iravani A.
    Antimicrob Agents Chemother; 1991 Apr; 35(4):750-2. PubMed ID: 2069382
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Review of in vitro activity, pharmacokinetic characteristics, safety, and clinical efficacy of cefprozil, a new oral cephalosporin.
    Barriere SL.
    Ann Pharmacother; 1993 Sep; 27(9):1082-9. PubMed ID: 8219444
    [Abstract] [Full Text] [Related]

  • 13. Cefprozil versus cefaclor in the treatment of mild to moderate skin and skin-structure infections. The Cefprozil Multicenter Study Group.
    Parish LC, Doyle CA, Durham SJ, Wilber RB.
    Clin Ther; 1992 Sep; 14(3):458-69. PubMed ID: 1638587
    [Abstract] [Full Text] [Related]

  • 14. Cefaclor into the millennium.
    Brumfitt W, Hamilton-Miller JM.
    J Chemother; 1999 Jun; 11(3):163-78. PubMed ID: 10435677
    [Abstract] [Full Text] [Related]

  • 15. [Clinical study of S 6472 in urinary tract infection].
    Takagi S, Arakawa S, Matsumoto O, Kamidono S, Hirooka K, Hamami G, Ishigami J, Umezu K, Yamanaka N, Sugimoto M.
    Jpn J Antibiot; 1990 Nov; 43(11):1850-72. PubMed ID: 2287054
    [Abstract] [Full Text] [Related]

  • 16. Loracarbef versus cefaclor in the treatment of cystitis and asymptomatic bacteriuria.
    Iravani A.
    Clin Ther; 1992 Nov; 14(1):54-63. PubMed ID: 1576626
    [Abstract] [Full Text] [Related]

  • 17. Loracarbef (LY163892) versus cefaclor and norfloxacin in the treatment of uncomplicated pyelonephritis.
    Hyslop DL, Bischoff W.
    Am J Med; 1992 Jun 22; 92(6A):86S-94S. PubMed ID: 1621752
    [Abstract] [Full Text] [Related]

  • 18. Treatment of pharyngitis and tonsillitis with cefprozil: review of three multicenter trials.
    McCarty JM, Renteria A.
    Clin Infect Dis; 1992 Jun 22; 14 Suppl 2():S224-30; discussion S231-2. PubMed ID: 1617042
    [Abstract] [Full Text] [Related]

  • 19. Cefprozil, a new cephalosporin: its use in various clinical trials.
    Gainer RB.
    South Med J; 1995 Mar 22; 88(3):338-46. PubMed ID: 7886533
    [Abstract] [Full Text] [Related]

  • 20. Comparative in-vitro activity of cefaclor against urinary tract isolates of Escherichia coli.
    Webster CA, Curran R, Towner KJ.
    J Antimicrob Chemother; 1996 Jul 22; 38(1):59-66. PubMed ID: 8858457
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.